Latest news

News archive

Vd Andreas Bhagwani presenterar Nanologica på Börsveckans småbolagsdag

19 February, 2020

Den 19 februari kl 10.45 presenterar vd Andreas Bhagwani Nanologica på Börsveckans småbolagsdag. Sändningen går att följa live eller ses i efterhand via länken: Nanologica presenterar vid Börsveckans småbolagsdag

Nanologica presenterar på Börsveckans småbolagsdag 19 feb

13 February, 2020

Nanologica presenterar på Börsveckans småbolagsdag den 19 februari kl 10.45. Presentationen kan ses via länken https://tv.streamfabriken.com/2020-02-19-nanologica Anmälan att delta vid evenemanget görs via denna länk: https://financialhearings.com/event/11337

Nanologicas delårsrapport jan-mar 2017

19 May, 2017

Nanologica delårsrapport jan-mars 2017

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.

Latest news

Categories

News archive

Vd Andreas Bhagwani presenterar Nanologica på Börsveckans småbolagsdag

Nanologica presenterar på Börsveckans småbolagsdag 19 feb

Nanologicas delårsrapport jan-mar 2017